Laxmi Dental Ltd. · NSE:LAXMIDENTL
Laxmi Dental — Q2 FY27 Earnings Presentation
38 slides from Laxmi Dental's earnings presentation, Nov 3, 2026
Slide 1: Exchange filing cover letter
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: [email protected]; [email protected] | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27
Slide 2: Laxmi Dental Limited Investor Presentation November 2026
LAXMI DENTAL LIMITED Investor Presentation November 2026 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Laxmi Dental Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securit
Slide 4: Table of Contents
Table of Contents 1 Slide 4 - 11 Q2 & H1 FY27 Performance & Financials Slide 4 - 11 2 Slide 12 - 29 Business Overview Slide 12 - 29 3 Slide 30 - 34 Historical Financial Statements Slide 30 - 34 4 Slide 35 - 36 Annexure Slide 35 - 36 3
Slide 5: Q2 & H1 FY27 Performance & Financials
1 Q2 & H1 FY27 Performance & Financials 4
Slide 6: Management Messages
Management Messages Rajesh Vrajlal Khakhar Sameer Kamlesh Merchant Chairperson and Whole-time Director Managing Director and CEO “We are delighted to report another strong quarter, building on the positive start we made to FY27. “During Q2FY27, the Company delivered a strong performance across segme
Slide 7: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Consolidated P&L (INR mn) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY 1 Q2 FY27 Performance Highlights Revenue from operations 795.2 722.7 10.0% 747.0 6.5% 1,542.2 1,378.6 11.9% Cost of Goods Sold 183.3 227.4 160.0 343.3 402.5 • Highest-ever quarterly reven
Slide 8: Financial Highlights
Financial Highlights (INR mn) 2 Revenue from operations1 EBITDA & Adjusted EBITDA PAT & PAT margin 100% Revenue - Paediatric: 1 Kids-e-Dental 795 15.3% 19.2% 19.2% 11.8% 13.8% 12.6% 723 747 EBITDA Margin (%) PAT Margin (%) 160 153 160 137 144 110 103 100 68 63 85 54 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY2
Slide 9: Revenue Mix
Revenue Mix (INR mn) Laboratory offerings* Aligner Solutions* Scanner Sales +22.7% 502 477 410 +23.5% 244 247 242 237 185 200 119 132 -60.7% 103 89 225 235 258 118 35 97 115 22 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 +23.1% 979 +26.0% 795 486 485 361 385 251 -61.3% 197 148 434
Slide 10: Revenue by Business Segments
Revenue by Business Segments (INR mn) INR mn Q2FY27 Q2FY26 YoY H1FY27 H1FY26 YoY Laboratory offerings Domestic laboratory 258.3 224.6 15.0% 492.7 434.4 13.4% International laboratory 244.0 184.8 32.0% 486.1 361.0 34.7% Scanner sales 36.1 87.5 -58.8% 59.6 145.0 -58.9% Laboratory offerings 538.3 496.9
Slide 11: Consolidated Statement of Assets and Liabilities
Consolidated Statement of Assets and Liabilities (INR mn) Particulars (As at) 30-Sep-26 31-Mar-26 Particulars (As at) 30-Sep-26 31-Mar-26 ASSETS EQUITY AND LIABILITIES 1) Equity 1) Non-Current Assets Equity Share Capital 110.1 109.9 Property, Plant and Equipment 567.6 467.2 Other Equity 2,538.3 2,32
Slide 12: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows (INR mn) Particulars (For the period) H1FY27 H1FY26 Profit before tax 237.8 190.2 Adjustments 86.6 69.6 Operating profit before working capital changes 324.3 259.8 Changes in working capital (141.7) (419.4) Cash generated from operations 182.7 (159.7) Direct taxe
Slide 13: Business Overview
2 Business Overview 12
Slide 14: India's Only End-to-End Integrated Dental Products Company
India’s Only End-to-End Integrated Dental Products Company Dental laboratory – Illusion Zirconia KEY STATS Crowns, bridges, dentures and zirconia & PFM restorations, made to order for India, the USA, the UK and Europe 22,000+ 320+ Dental Network Cities across India Aligners (B2B2C) – Illusion Aligne
Slide 15: Our Journey: Evolving with the Future of Dentistry
Our Journey: Evolving with the Future of Dentistry The journey began Launched Brand visibility Digital ecosystem Rajesh Vrajlal Khakhar, Expanded into dental materials Chairperson and Whole- and equipment through Vedia Actress appointed as a Reached 75% digital time Director, started a Solutions and
Slide 16: A Large, Growing Market Moving to Organised, Digital Labs
A Large, Growing Market Moving to Organised, Digital Labs Crowns & bridges1 Clear aligners Paediatric crowns KEY GROWTH DRIVERS GLOBAL MARKET US$ bn 8% CAGR US$ bn 15% CAGR US$ bn 8% CAGR • Organised global market with large dental chains and DSOs 121.6 54.9 3.5 • Preference for superior quality, fa
Slide 17: A Comprehensive Portfolio for Modern Dentistry
A Comprehensive Portfolio for Modern Dentistry A comprehensive portfolio for modern dentistry Aligners – Bizdent Dental Laboratory Aligners – Vedia (B2B) Paediatric Digital Dentistry Illusion Zirconia (B2B2C) Taglus materials & equipment Kids-e-Dental iScanPro · iScope 360 Illusion Aligners • Custom
Slide 18: Dental Laboratory: Top-2 Domestic Player & Largest Indian Exporter
Dental Laboratory: Top-2 Domestic Player & Largest Indian Exporter FY26 FY25 ➢ Inclusion of dental crowns, bridges and Domestic · Top-2 International · Largest Indian resins as Class B risk Medical Device by player exporter the regulatory authority CDSCO Dental lab revenue 1,667.7 1,408.9 ➢ Complian
Slide 19: Aligners: Largest Indigenous & Vertically Integrated Aligner Company
Aligners: Largest Indigenous & Vertically Integrated Aligner Company FY26 FY25 B2B2C · Bizdent B2B · Vedia Solutions Devices Taglus / Vedia revenue (INR mn) 337.9 289.0 Illusion Aligners revenue (INR mn) 393.8 394.8 Revenue by cities (Illusion Aligners) Tier I cities 43.35% 54.72% Tier II cities 35.
Slide 20: Kids-e-Dental: Specialised Paediatric Dental Products
Kids-e-Dental: Specialised Paediatric Dental Products Kids-e-Dental LLP (100%) FY26 FY25 Revenue (INR mn) 210.6 262.7 Flagship Bioflx: semi-flexible, tooth-coloured, pre-formed crown with a registered Indian design Domestic 38.6% 26.1% PRODUCT RANGE International 61.4% 73.9% • Bioflx & other pre-for
Slide 21: Digital Dentistry & iScanPro: Connecting the Dental Care Journey
Digital Dentistry & iScanPro: Connecting the Dental Care Journey Conventional workflow Shipped to lab Converted to digital impression Collected by sales / logistics team (logistics time depends on distance) (6-step process) Physical impression Design & manufacturing Delivery to dentist (24 to 48 hou
Slide 22: Innovation: New Orthodontic Products, iScope 360 and AI Dent
Innovation: New Orthodontic Products, iScope 360 and AI Dent Teen Aligners & PEOT iScope 360 AI Dent Launched in FY26 Launched in FY27 Strategic investment (49% JV) • Expanded the Illusion Aligners portfolio beyond • AI-enabled remote dental platform that pairs with • Investment in IDBG AI Dent Glob
Slide 23: Branded Portfolio & Engaging the Dental Ecosystem
Branded Portfolio & Engaging the Dental Ecosystem Branded Portfolio and Marketing Focus Aesthetic restorative Dentist-prescribed Aligner materials and Paediatric dental Digital dentistry solutions aligner solutions equipment products solutions Engaging the Dental Ecosystem Brand communication, profe
Slide 24: Connecting Dental Care across Geographies
Connecting Dental Care across Geographies Geographic revenue mix FY26 (%) India 64.4 USA 19.4 UK 10.1 Others 6.1 Network Advantage • Large Dental Network strengthens brand visibility, attracts dental professionals and enhances product credibility • Growing international network creates synergies and
Slide 25: Manufacturing, Supporting and Export Infrastructure
Manufacturing, Supporting and Export Infrastructure Six manufacturing facilities Eight supporting facilities Certified 2 1 1 1 2 3 1 Mumbai Delhi Bengaluru Ahmedabad Mira Road, MH Boisar, MH Kochi, Kerala 1 1 1 Surat Vadodara Chennai ~1,75,000 sq. ft. total 1 export laboratory at SEEPZ operating as
Slide 26: Management team with significant industry experience (1/2)
Management team with significant industry experience…(1/2) Promoters & Key Management Rajesh Vrajlal Khakhar Sameer Kamlesh Merchant Dharmesh Dattani Chairperson and Whole-time Managing Director and CEO Chief Financial Officer Director • Responsible for managing business partnerships • Responsible f
Slide 27: Management team with significant industry experience (2/2)
Management team with significant industry experience…(2/2) Directors Key Managerial & Senior Management Personnel • Qualified Company Secretary and a Law Graduate from the University of Mumbai, • Bachelor’s degree in mechanical engineering from the Indian Institute of with extensive experience in co
Slide 28: IPO Proceeds to be Deployed to Build an Owned Lab & Aligner Plant
IPO Proceeds to be Deployed to Build an Owned Lab & Aligner Plant FROM: UNUTILISED ORIGINAL OBJECTS TO: NEW OBJECTS (FY27–FY28) IPO PROCEEDS STATUS ₹25.7 Cr ₹26.9 Cr Land & building – new dental lab & aligner 64% New machinery – Laxmi of ₹128.2 Cr net IPO proceeds manufacturing plant ₹17.8 Cr of ₹43
Slide 29: Awards and Recognitions
Awards and Recognitions 2018 2019 2021 2022 2023 2024 2026 Famdent Famdent Famdent Famdent Style Italiano India Book of ‘Innovative Dental Excellence in Excellence in Excellence in Excellence: Award, 1st India Records: the Lab of the Year’, Dentistry Award Dentistry Award Dentistry, Aligner Innovati
Slide 30: Key Highlights
Key Highlights India’s Only Integrated Dental Products Leadership in Domestic and Export Vertically Integrated, Diversified 1 2 3 Company Dental Labs Branded Portfolio • Lab, aligners, materials, scanners and paediatric • Second-largest domestic lab and largest export • Illusion Zirconia, Illusion A
Slide 31: Historical Financial Statements
3 Historical Financial Statements 30
Slide 32: Revenue by Segment: FY23–FY26
Revenue by Segment: FY23–FY26 Laboratory business (INR mn)1 Aligner solutions (INR mn)1 100% Revenue - Paediatric: Kids-e-Dental2 Domestic International Bizdent Vedia 18% CAGR 28% CAGR 38% CAGR FY23–FY26 FY23–FY26 FY23–FY26 267 263 1,668 732 684 1,409 211 1,208 784 540 338 289 1,011 607 440 192 383
Slide 33: Consolidated Statement of Profit and Loss
Consolidated Statement of Profit and Loss Consolidated P&L (INR mn) FY26 FY25 FY24 FY23 FY22 Revenue from operations¹ 2,778.6 2,391.1 1,935.6 1,616.3 1,368.5 Cost of Goods Sold 821.9 572.4 484.9 418.0 396.6 Gross Profit 1,956.7 1,818.7 1,450.7 1,198.3 972.0 Gross Profit Margin 70.4% 76.1% 74.9% 74.1
Slide 34: Consolidated Statement of Assets and Liabilities
Consolidated Statement of Assets and Liabilities INR mn Particulars (As at) 31-Mar-26 31-Mar-25 31-Mar-24 31-Mar-23 31-Mar-22 Particulars (As at) 31-Mar-26 31-Mar-25 31-Mar-24 31-Mar-23 31-Mar-22 ASSETS EQUITY AND LIABILITIES 1) Equity 1) Non-Current Assets Equity Share Capital 109.9 109.9 3.1 3.1 3
Slide 35: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows Particulars (For the period) FY26 FY25 FY24 FY23 FY22 Profit before tax 347.0 310.2 69.2 (45.8) (161.6) Adjustments 95.3 133.8 178.2 153.1 232.2 Operating profit before working capital changes 442.3 444.0 247.4 107.3 70.6 Changes in working capital (425.5) 19.3 (
Slide 36: Annexure
4 Annexure ,2@2p 35)
Slide 37: Abbreviations
Abbreviations Term Description B2B Business-to-Business B2B2C Business-to-Business-to-Consumer B2C Business-to-Consumer CAGR Compound Annual Growth Rate CAD Computer Aided Design CAM Computer Aided Manufacturing CDSCO Central Drugs Standard Control Organization EBITDA refers to earnings before inter
Slide 38: Thank You
Thank You Company: Laxmi Dental Limited CIN: L51507MH2004PLC147394 Suman Saha, Company Secretary & Compliance Officer Email id: [email protected] Investor Relations Advisor: Strategic Growth Advisors Pvt Ltd. CIN: U74140MH2010PTC204285 Dharmik Kansara / Shikha Puri Email id: dharmik.k@sg